• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vir Biotechnology Inc (NQ: VIR )

    9.420 -0.450 (-4.56%)
    Streaming Delayed Price Updated: 11:02 AM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vir Biotechnology Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    VIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024
    VIR stock results show that Vir Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
    From Vir Biotechnology, Inc.
    Via Business Wire
    Assessing Vir Biotechnology: Insights From 5 Financial Analysts
    Via Benzinga
    Recap: Vir Biotechnology Q4 Earnings
    Via Benzinga
    Earnings Outlook For Vir Biotechnology
    Via Benzinga
    JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know
    Via Benzinga
    Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
    From Vir Biotechnology, Inc.
    Via Business Wire
    From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
    These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations. 
    Via InvestorPlace
    Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
    One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. 
    Via InvestorPlace
    Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
    From Vir Biotechnology, Inc.
    Via Business Wire
    3 Highly Rated Biotech Stocks to Buy for 300% Gains
    Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings. 
    Via InvestorPlace
    Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. 
    Via Benzinga
    Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
    U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
    From Vir Biotechnology, Inc.
    Via Business Wire
    3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
    Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation. 
    Via InvestorPlace
    Earnings Scheduled For February 22, 2024
    Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
    Via Benzinga
    Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
    From Vir Biotechnology, Inc.
    Via Business Wire
    HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here's What You Need To Know
    Via Benzinga
    COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
    COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n 
    Via Benzinga
    Exposures COVID-19
    Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
    From Vir Biotechnology, Inc.
    Via Business Wire
    7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
    explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy 
    Via InvestorPlace
    From laggards to leaders: Small caps on the rise
    Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains. 
    Via MarketBeat
    Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
    From Vir Biotechnology, Inc.
    Via Business Wire
    Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
    From Vir Biotechnology, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.